Esperion治療ESPR

那斯達克 · USD
3.13
0.00
(0.00%)
收盤 06/06 03:59 (UTC+8)
06/06 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.32
  • 1.38
  • 0.74
  • 0.52
  • 0.69
  • 0.65
  • 0.82
  • 0.87
  • 1.68
  • 0.80
icon
  • -5.06
  • 327.09
  • -46.39
  • -30.07
  • 33.86
  • -5.96
  • 26.76
  • 5.98
  • 92.93
  • -52.45
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
營業收入淨額
80,104
168,446
87,309
82,385
64,995
69,113
51,632
73,834
137,735
32,250
營業成本
34,57327,85441,28928,54331,53825,63117,28615,60910,07511,452
營業毛利
45,531
140,592
46,020
53,842
33,457
43,482
34,346
58,225
127,660
20,798
營業費用
52,11255,35955,97946,747-----63,165
研發費用
8,98813,92614,1317,23812,55710,97710,39711,46113,40317,742
推銷及管理費用
43,12441,43341,84839,50942,99636,92539,97544,18541,98845,423
非經常性項目費用
----------
其他營業費用
----------
營業利益
-6,581
85,233
-9,959
7,095
-22,096
-4,420
-16,026
2,579
72,269
-42,367
其他收入及費用
1,1831,0756776661,072-4761,584-50,7812,7771,080
利息費用
19,79822,63622,05120,48619,43116,42215,08213,72314,02415,057
稅前純益
-25,196
63,672
-31,333
-12,725
-40,455
-21,318
-29,524
-61,925
61,022
-56,344
所得稅
-1,841--------
稅後純益
-25,196
61,831
-31,333
-12,725
-40,455
-21,318
-29,524
-61,925
61,022
-56,344
基本每股稅後盈餘(元)
-0.100.26-0.16-0.02-0.21-0.11-0.15-0.330.36-0.50
稀釋每股稅後盈餘(元)
-0.100.32-0.16-0.06-0.21-0.11-0.16-0.350.34-0.50
基本平均股數(千股)
251353.00236682.00200736.00197546.00196127.00195566.00194930.00188793.00169258.00112403.00
稀釋平均股數(千股)
251353.00284573.00200736.00197546.00196127.00195566.00194930.00188793.00189641.00112403.00
還原基本每股稅後盈餘(元)
-0.100.26-0.16-0.02-0.21-0.11-0.15-0.330.36-0.50
還原稀釋每股稅後盈餘(元)
-0.100.32-0.16-0.06-0.21-0.11-0.16-0.350.34-0.50
還原基本平均股數(千股)
251,353236,682200,736197,546196,127195,566194,930188,793169,258112,403
還原稀釋平均股數(千股)
251,353284,573200,736197,546196,127195,566194,930188,793189,641112,403
EBITDA(千元)
-4,78286,975-8,4098,608-20,299-4,697-13,969-47,75075,483-40,850

大家都在看

HOT